
Adam Maeder
Stock Analyst at Piper Sandler
(4.78)
# 604
Out of 5,189 analysts
361
Total ratings
55.4%
Success rate
13.8%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSPR InspireMD | Reiterated: Buy | $3 | $0.54 | +455.56% | 9 | Nov 13, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $160 → $150 | $94.72 | +58.36% | 2 | Nov 6, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $101 → $115 | $101.85 | +12.91% | 58 | Nov 5, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $9 → $12 | $10.18 | +17.88% | 10 | Nov 5, 2026 | |
| RXST RxSight | Reiterated: Hold | $10 → $8 | $4.47 | +78.97% | 11 | Nov 4, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $60 → $70 | $55.10 | +27.04% | 52 | Nov 3, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $118 | $103.00 | +14.56% | 22 | Nov 2, 2026 | |
| RMD ResMed | Reiterated: Hold | $225 → $260 | $235.63 | +10.34% | 9 | Oct 30, 2026 | |
| GKOS Glaukos | Reiterated: Buy | $195 → $240 | $237.31 | +1.13% | 21 | Oct 29, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $470 | $399.05 | +17.78% | 54 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $24.70 | +1.21% | 1 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $90 | $90.73 | -0.80% | 34 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 | $24.22 | +36.25% | 7 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3.5 | $0.9422 | +271.47% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $25.60 | +64.06% | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 → $3 | $1.25 | +140.00% | 13 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.5 → $7 | $0.001 | n/a | 12 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $48.38 | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.57 → $2.14 | $0.09 | n/a | 2 | Dec 23, 2019 |
InspireMD
Nov 13, 2026
Reiterated: Buy
Price Target: $3
Current: $0.54
Upside: +455.56%
iRhythm Holdings
Nov 6, 2026
Reiterated: Buy
Price Target: $160 → $150
Current: $94.72
Upside: +58.36%
Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $101 → $115
Current: $101.85
Upside: +12.91%
Sight Sciences
Nov 5, 2026
Reiterated: Buy
Price Target: $9 → $12
Current: $10.18
Upside: +17.88%
RxSight
Nov 4, 2026
Reiterated: Hold
Price Target: $10 → $8
Current: $4.47
Upside: +78.97%
Inspire Medical Systems
Nov 3, 2026
Reiterated: Hold
Price Target: $60 → $70
Current: $55.10
Upside: +27.04%
Abbott Laboratories
Nov 2, 2026
Reiterated: Buy
Price Target: $118
Current: $103.00
Upside: +14.56%
ResMed
Oct 30, 2026
Reiterated: Hold
Price Target: $225 → $260
Current: $235.63
Upside: +10.34%
Glaukos
Oct 29, 2026
Reiterated: Buy
Price Target: $195 → $240
Current: $237.31
Upside: +1.13%
Intuitive Surgical
Oct 21, 2026
Reiterated: Buy
Price Target: $470
Current: $399.05
Upside: +17.78%
Oct 16, 2026
Reiterated: Buy
Price Target: $25
Current: $24.70
Upside: +1.21%
Sep 2, 2026
Reiterated: Buy
Price Target: $87 → $90
Current: $90.73
Upside: -0.80%
Aug 13, 2026
Reiterated: Hold
Price Target: $33
Current: $24.22
Upside: +36.25%
May 13, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $0.9422
Upside: +271.47%
May 5, 2026
Reiterated: Buy
Price Target: $42
Current: $25.60
Upside: +64.06%
Apr 7, 2026
Reiterated: Buy
Price Target: $5.5 → $3
Current: $1.25
Upside: +140.00%
Aug 13, 2025
Reiterated: Hold
Price Target: $8.5 → $7
Current: $0.001
Upside: n/a
Apr 9, 2020
Initiated Coverage: Buy
Price Target: $74
Current: $48.38
Upside: n/a
Dec 23, 2019
Reiterated: Buy
Price Target: $3.57 → $2.14
Current: $0.09
Upside: n/a